Summary
Progressive disseminated histoplasmosis (PDH) has been described in only six patients with hairy cell leukemia (HCL). Herein we describe an additional patient with HCL and disseminated histoplasmosis. Additionally, we note that three of seven cases of disseminated histoplasmosis and HCL have occurred in East Texas. PDH is to be suspected in febrile HCL patients in an endemic area who fail to respond to antibacterial therapy. We emphasize that serologic studies are useful in the diagnosis of PDH in HCL patients, and these patients respond well to therapy.
Similar content being viewed by others
References
Anderson KC, Boyd AW, Fisher DC, Leslie D, Schlossman SF, Nadler LM (1985) Hairy cell leukemia: a tumor of pre-plasma cells. Blood 65: 620–629
Baldini L, Cortelezzi A, Polli N, Neri A, Nobili L, Maiolo AT, Lambergenghi-Deliliers G, Polli EE (1986) Human recombinant interferon α-2 C enhances the expression of class-II HLA antigens of hairy cells. Blood 67: 458–464
Bennett CL, Westbrook CA, Gruber B, Golomb HM (1986) Hairy cell leukemia and mucormycosis. Am J Med 81: 1065–1067
Bouroncle BA (1979) Leukemic reticuolendotheliosis (hairy cell leukemia). Blood 53: 609–630
Bouroncle BA, Wiesman BK, Doan CA (1958) Leukemic reticuloendotheliosis. Blood 13: 509–630
Bouza E, Burgaleta C, Golde DW (1978) Infections in hairy cell leukemia. Blood 51: 851–859
Child JA, Cawley JC, Martin S, McGhoneim AT (1979) Microbicidal function of the neutrophils in hairy-cell leukaemia. Acta Haematol (Basel) 62: 191–198
Cox F, Hughes WT (1974) Disseminated histoplasmosis and childhood leukemia. Cancer 33: 1127–1133
Daves SF, Khan M, Sarosi GA (1978) Disseminated histoplasmosis in immunology-suppressed patients. Am J Med 64: 95–100
Deepe GS jr (1988) Protective immunity in murine histoplasmosis; Functional comparison of adoptively transferred T-cell clones and splenic T-cells. Infect Immun 65: 2350–2355
Dismukes WE, Royal SA, Tynes BS (1978) Disseminated histoplasmosis in corticosteroid-treated patients. Report of five cases. JAMA 240: 1495–1498
Edwards IB, Acquaviva FA, Livesay VT, et al. (1969) An atlas of sensitivity to tuberculin. PPD-B and histoplasmosis in the UNited States. Am Rev Respir Dis 99: 1
Golomb HM, Hadad LJ (1984) Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol 16: 393–401
Golomb HM, Hanover SB (1981) Infectious complications associated with hairy cell leukemia. J Infect Dis 5: 639–643
Goodwin RA, Shapiro JL, Thurman GH, et al. (1980) Disseminated histoplasmosis: Clinical and pathologic correlations. Medicine (Baltimore) 59: 1–33
Gualtieri RJ, Wheby MS (1984) Hairy cell leukemia: a case of cryptococcosis appearing as hairy cell meningitis. South Med J 77: 1341–1342
Hersch EV, Quesada J, Keating MJ, Rasmussen S, Murphy SG, Gschwind C, Morgan J (1982) Host defense factors and prognosis in hairy cell leukemia. Leukemia Res 6: 625–637
Hsu S-M, Yang K, Jaffé ES (1983) Hairy cell leukemia: a B-cell neoplasm with a unique antigenic phenotype. Am J Clin Pathol 80: 421–428
Janckila AJ, Wallace JH, Yam LT (1982) Generalized monocyte deficiency in leukaemic reticuloendotheliosis. Scan J Haematol 29: 153–160
Johnson PC, Khardoi N, Najjar AF, et al. (1988) Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 85: 152–158
Katayama I, Finkel HL (1974) Leukemic reticuloendotheliosis. A clinicopathologic study with review of the literature. Am J Med 57: 115–126
Kauffman CA, Israel KS, Smith JW, White AC, Schwarz J, Brooks GF (1978) Histoplasmosis in immunosuppressed patients. Am J Med 64: 923–932
Lehmann PF, Gibbons J, Senitzer D, Ribner BS, Freimer EH (1983) T-lymphocyte abnormalities in disseminated histoplasmosis. J Med 75: 790–794
Libshitz HI, Shuman LS, Gresik MV, Heaston DK (1981) Pneumonia in hairy cell leukemia. Radiology 139: 19–24
Mackowiak PA, Demian SE, Sutker WL, et al. (1980) Infections in hairy cell leukemia. Clinical evidence of a pronounced defect in cell-mediated immunity. Am J Med 68: 718–724
Mackowiak PA, Demian SE, Sutker WL, Murphy FK, Smith JW, Tompsett R, Sheehan WW, Luby JP (1980) Infections in hairy cell leukemia. Clinical evidence of a pronounced defect in cell-mediated immunity. Am J Med 68: 718–724
Mario JP, Degas L, Flandrin G (1977) Hairy cell leukemia and tuberculosis. (Letter) N Engl J Med 296: 354
Palmer CE (1946) Geographic differences in sensitivity to histoplasmin among student nurses. Public Health Rep 61: 475
Payan DG, Wheat LJ, Brahmi Z, Ip S, Hansen WP, Hoffman RA, Healey K, Rubin RH (1984) Changes in immunoregulatory lymphocyte populations in patients with histoplasmosis. J Clin Immunol 4: 98–107
Posnett DN, Duggan A, McGrath H (1990) Hairy cell leukemia-associated antigen (HC2) is an activation antigen of several hemopoietic cell lineages, inducible on monocytes by IFN-γ1. J Immunol 144: 929–933
Rex JH, Harris RL, Wheeler, et al. (1985) Granulomatous disease complicating hairy cell leukemia. Tex Med 81: 31–33
Rice L, Shenkenberg T, Lynch EC, et al. (1982) Granulomateus infections complicating hairy cell leukemia. Cancer 49: 1924–1928
Rice L, Shenkenburg T, Lynch EC, Wheeler TM (1982) Granulomatous infections complicating hairy cell leukemia. Cancer 49: 1924–1928
Rich AR (1930) The demonstration that allergic inflammation is not necessary for the operation of acquired immunity. Proc Natl Acvad Sci USA 16: 460–464
Rich AR, McCordock HA (1929) An enquiry concerning the role of allergy, immunity and other factors of importance in the pathogenesis of human tuberculosis. Bull Johns Hopkins Hosp 44: 273–423
Rich AR, Jennings FB jr, Downing LM (1933) The persistence of immunity after the abolition of allergy by desensitization. Bull John Hopkins Hosp 53: 172–196
Sathapatayavongs B, Batteiger BE, Wheat J, Slama TG, Wass JL (1983) Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 62: 263–270
Seshadri RS, Brown EJ, Zipursky A (1976) Leukemic reticuloendotheliosis. A failure of monocyte production. N Engl J Med 295: 181–184
Stewart DJ, Bodey GP (1981) Infections in hairy cell leukemia (leukemic reticuloendotheliosis). Cancer 47: 801–805
Sugar AM, Stevens DA (1985)Candida rugosa in immunocompromised infection. Cancer 56: 318–320
Trentin L, Zambello R, Agostini C, Ambrosetti A, Chisesi T, Raimondi R, Bulian P, Pizzolo G, Semenzato G (1990) Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood 75: 1525–1530
Wheat J, French MLV, Kohler RB, Zimmerman SE, Smith WR, Norton JA, Eitzen HE, Smith CD, Slama TG (1982) The diagnostic laboratory tests for histoplasmosis — analysis of experience in a large urban outbreak. Ann Intern Med 97: 680–685
Wheat LJ, Slama TG, Norton JA, et al. (1982) Risk factors for disseminated or fatal histoplasmosis. Ann Intern Med 96: 159–163
Wu-Hsieh B, Howard DH (1984) Inhibition of growth ofHistoplasma capsulatum by lymphokine-stimulated macrophages. J Immunol 132: 2593–2597
Author information
Authors and Affiliations
Additional information
Dr. Weeks was supported by a Training Grant from the American Cancer Society to MD Anderson Cancer Center Medical School Houston, Texas 77030, 6431 Fannin Street, Rm 5016 M.S.M.B.
Rights and permissions
About this article
Cite this article
Weeks, E., Jones, C.M., Guinee, V. et al. Histoplasmosis in hairy cell leukemia: Case report and review of the literature. Ann Hematol 65, 138–142 (1992). https://doi.org/10.1007/BF01695814
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01695814